Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.90
+0.01 (0.15%)
At close: Feb 26, 2026, 4:00 PM EST
6.90
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:04 PM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $503.61 million as of February 26, 2026. Its market cap has increased by 229.55% in one year.
Market Cap
503.61M
Enterprise Value
382.01M
1-Year Change
229.55%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $503.61M, an increase of 85.59%. That is a compound annual growth rate of 30.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 502.88M | -30.61% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 503.57M |
| vTv Therapeutics | 494.25M |
| Zura Bio | 492.92M |
| Lyell Immunopharma | 490.10M |
| Eupraxia Pharmaceuticals | 488.84M |
| Autolus Therapeutics | 484.38M |
| Vanda Pharmaceuticals | 482.91M |
| Prothena Corporation | 482.85M |